SERINA THERAPEUTICS, INC., 10-K/A filed on 3/27/2026
Amended Annual Report
v3.26.1
Cover - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Mar. 18, 2026
Jun. 30, 2025
Cover [Abstract]      
Document Type 10-K/A    
Document Annual Report true    
Current Fiscal Year End Date --12-31    
Document Period End Date Dec. 31, 2025    
Document Transition Report false    
Entity File Number 1-38519    
Entity Registrant Name Serina Therapeutics, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 82-1436829    
Entity Address, Address Line One 601 Genome Way    
Entity Address, Address Line Two Suite 2001    
Entity Address, City or Town Huntsville    
Entity Address, State or Province AL    
Entity Address, Postal Zip Code 35806    
City Area Code (256)    
Local Phone Number 327-9630    
Title of 12(b) Security Common Stock, par value $0.0001 per share    
Trading Symbol SER    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 21.8
Entity Common Stock, Shares Outstanding   12,314,159  
Documents Incorporated by Reference [Text Block]
Portions of the registrant’s definitive proxy statement to be filed for the registrant’s 2026 Annual Meeting of Stockholders are incorporated by reference into Part III hereof. Such proxy statement will be filed with the Securities and Exchange Commission within 120 days of the end of the fiscal year covered by this Annual Report on Form 10-K.
    
Entity Central Index Key 0001708599    
Document Fiscal Year Focus 2025    
Amendment Flag false    
Document Fiscal Period Focus FY